Psychemedics (Psychemedics) Long-Term Capital Lease Obligation : $0.95 Mil (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

Psychemedics Long-Term Capital Lease Obligation Definition

Psychemedics's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.95 Mil.

Psychemedics's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 ($1.47 Mil) to Sep. 2023 ($1.21 Mil) and declined from Sep. 2023 ($1.21 Mil) to Dec. 2023 ($0.95 Mil).

Psychemedics's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($2.88 Mil) to Dec. 2022 ($1.94 Mil) and declined from Dec. 2022 ($1.94 Mil) to Dec. 2023 ($0.95 Mil).

Psychemedics Long-Term Capital Lease Obligation Historical Data

The historical data trend for Psychemedics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psychemedics Long-Term Capital Lease Obligation Chart

Psychemedics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.38

3.90

2.88

1.94

0.95

Psychemedics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.94	1.72	1.47	1.21	0.95

Psychemedics (NAS:PMD) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Psychemedics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Psychemedics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Psychemedics (Psychemedics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psychemedics Corp (NAS:PMD) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

289 Great Road, Suite 200, Acton, MA, USA, 01720

Website

https://www.psychemedics.com

Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. Geographically it generates the majority of its revenue from the United States.

Executives

Shannon Shoemaker	officer: Chief Revenue Officer	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Charles M Doucot	officer: Executive Vice President	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Andrew Reynolds	director	C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Brian Hullinger	director, officer: President & CEO	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Robyn C Davis	director	ONE WALLINGFORD ROAD, MARBLEHEAD MA 01945
Michael Weisenhoff	other: Assistant Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Michael I Schaffer	officer: VP of Laboratory Operations	C/O PAYCHEMEDICS CORP, 1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138
William B. Norris	other: Assistant Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Darius G Nevin	other: See Footnote 1	C/O WCI COMMUNITIES, INC., 24301 WALDEN CENTER DRIVE, BONITA SPRINGS FL 34134
Peter H Kamin	10 percent owner	2720 DONALD ROSS ROAD, #311, PALM BEACH GARDENS FL 33410
Andrew Limbek	officer: Vice President & Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Fred J Weinert	director	330 E MAIN ST, BARRINGTON IL 60620
Kubacki Raymond C Jr	director, officer: Chairman, CEO & President	125 NAGOG PARK, ACTON MA 01720
A Clinton Allen	director, officer: Chairman	1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138
Neil Lerner	officer: VP - Finance	C/O PSYCHEMEDICS CORPORATION, 125 NAGOG PARK, ACTON MA 01720